msh--4-nle-7-phe-alpha- and Arrhythmias--Cardiac

msh--4-nle-7-phe-alpha- has been researched along with Arrhythmias--Cardiac* in 1 studies

Other Studies

1 other study(ies) available for msh--4-nle-7-phe-alpha- and Arrhythmias--Cardiac

ArticleYear
Protective effect of melanocortin peptides in rat myocardial ischemia.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:3

    The influence of the melanocortin peptide ACTH-(1-24) (adrenocorticotropin) on the consequences of short-term coronary ischemia (5 min) followed by reperfusion, and the effect of the long-acting melanocortin [Nle(4),D-Phe(7)]alpha-melanocyte-stimulating hormone (NDP-MSH) on the damage induced by a permanent coronary occlusion, were investigated in anesthetized rats. Ischemia was produced by ligature of the left anterior descending coronary artery. Reperfusion-induced arrhythmias [ventricular tachycardia (VT), ventricular fibrillation (VF)] and survival rate within the 5 min following reperfusion, blood levels of free radicals detected 2 min after reperfusion by electron spin resonance spectrometry, and amount of healthy myocardial tissue, measured 72 h after permanent coronary occlusion on immunohistologically stained serial sections, were evaluated. Postischemic reperfusion induced VT in all saline-treated rats, and VF and death in a high percentage of animals (87%). In rats treated i.v. (2.5 min after coronary occlusion) with ACTH-(1-24) (0.16-0.48 mg/kg) there was a significantly dose-dependent reduction in the incidence of arrhythmias and lethality. Ischemia/reperfusion caused a large increase in free radical blood levels; treatment with ACTH-(1-24) (0.48 mg/kg i.v.) almost completely prevented this increase. In rats subjected to permanent coronary occlusion, the amount of healthy myocardial tissue was much reduced in saline-treated rats, while in rats treated s.c. with NDP-MSH (0.27 mg/kg every 12 h) it was significantly higher. The present data demonstrate, for the first time, an unforeseen property of melanocortin peptides, i.e., their ability to significantly reduce both heart ischemia/reperfusion injury and size of the ischemic area induced by permanent coronary occlusion.

    Topics: alpha-MSH; Animals; Arrhythmias, Cardiac; Coronary Disease; Cosyntropin; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Electron Spin Resonance Spectroscopy; Female; Free Radicals; Injections, Intravenous; Injections, Subcutaneous; Male; Myocardial Ischemia; Myocardial Reperfusion; Neuropeptides; Rats; Rats, Wistar; Reperfusion Injury; Survival Rate

2001